Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06711302

Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage

Remote Ischemic Conditioning for Efficacy in Patients With Aneurysmal Subarachnoid Hemorrhage: a Multi-center, Randomized, Double-blind, Sham-controlled, Parallel-group Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
500 (estimated)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Several recent large-scale clinical trials aimed at improving subarachnoid hemorrhage(SAH) outcomes have concluded with negative results, failing to enhance the prognosis for these patients. Consequently, there is an urgent demand for novel treatment strategies and approaches to address the challenges posed by SAH. Remote ischemic conditioning(RIC) has gained considerable attention in the treatment of stroke, particularly ischemic stroke, with numerous studies demonstrating its potential to enhance neurological outcomes compared to conventional treatments alone.RIC for the treatment of SAH is an investigative strategy in its initial stages. The neuroprotective effects of RIC, particularly its potential to preserve cranial nerve function and ameliorate neurological deficits, confer significant value in the treatment of SAH patients. The precise manner in which SAH patients may benefit from RIC treatment, and the mechanisms by which it improves neurological function, remain to be fully understood. Consequently, randomized controlled trials are necessary to validate the efficacy of RIC in this patient population and to delineate the optimal therapeutic protocols for its application. Based on the above discussion, this study aims to explore the efficacy and safety of RIC in the treatment of SAH.

Conditions

Interventions

TypeNameDescription
DEVICESham RICRemote Ischemic Conditioning is given twice a day with 60mmHg pressure.
DEVICERemote Ischemic Conditioning treatment instrumentRemote Ischemic Conditioning is given twice a day with 200mmHg pressure.

Timeline

Start date
2025-07-01
Primary completion
2026-01-01
Completion
2026-04-01
First posted
2024-12-02
Last updated
2025-07-10

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06711302. Inclusion in this directory is not an endorsement.